Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation

Hiroyuki Konishi, Bedri Karakas, Abde M. Abukhdeir, Josh Lauring, John P. Gustin, Joseph P. Garay, Yuko Konishi, Eike Gallmeier, Kurtis E. Bachman, Ho Park Ben

Research output: Contribution to journalArticle

Abstract

The oncogenic function of mutant ras in mammalian cells has been extensively investigated using multiple human and animal models. These systems include overexpression of exogenous mutant ras transgenes, conditionally expressed knock-in mouse models, and somatic cell knockout of mutant and wild-type ras genes in human cancer cell lines. However, phenotypic discrepancies between knock-in mice and transgenic mutant ras overexpression prompted us to evaluate the consequences of targeted knock-in of an oncogenic K-ras mutation in the nontumorigenic human breast epithelial cell line MCF-10A and hTERT-immortalized human mammary epithelial cells. Our results show several significant differences between mutant K-ras knock-in cells versus their transgene counterparts, including limited phosphorylation of the downstream molecules extracellular signal-regulated kinase and AKT, minor proliferative capacity in the absence of an exogenous growth factor, and the inability to form colonies in semisolid medium. Analysis of 16 cancer cell lines carrying mutant K-ras genes indicated that 50% of cancer cells harbor nonoverexpressed heterozygous K-ras mutations similar to the expression seen in our knock-in cell lines. Thus, this system serves as a new model for elucidating the oncogenic contribution of mutant K-ras as expressed in a large fraction of human cancer cells.

Original languageEnglish (US)
Pages (from-to)8460-8467
Number of pages8
JournalCancer Research
Volume67
Issue number18
DOIs
StatePublished - Sep 15 2007

Fingerprint

Epithelial Cells
Cell Line
ras Genes
Transgenes
Neoplasms
Breast
Mutation
Extracellular Signal-Regulated MAP Kinases
Transgenic Mice
Intercellular Signaling Peptides and Proteins
Animal Models
Phosphorylation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Konishi, H., Karakas, B., Abukhdeir, A. M., Lauring, J., Gustin, J. P., Garay, J. P., ... Ben, H. P. (2007). Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation. Cancer Research, 67(18), 8460-8467. https://doi.org/10.1158/0008-5472.CAN-07-0108

Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation. / Konishi, Hiroyuki; Karakas, Bedri; Abukhdeir, Abde M.; Lauring, Josh; Gustin, John P.; Garay, Joseph P.; Konishi, Yuko; Gallmeier, Eike; Bachman, Kurtis E.; Ben, Ho Park.

In: Cancer Research, Vol. 67, No. 18, 15.09.2007, p. 8460-8467.

Research output: Contribution to journalArticle

Konishi, H, Karakas, B, Abukhdeir, AM, Lauring, J, Gustin, JP, Garay, JP, Konishi, Y, Gallmeier, E, Bachman, KE & Ben, HP 2007, 'Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation', Cancer Research, vol. 67, no. 18, pp. 8460-8467. https://doi.org/10.1158/0008-5472.CAN-07-0108
Konishi, Hiroyuki ; Karakas, Bedri ; Abukhdeir, Abde M. ; Lauring, Josh ; Gustin, John P. ; Garay, Joseph P. ; Konishi, Yuko ; Gallmeier, Eike ; Bachman, Kurtis E. ; Ben, Ho Park. / Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation. In: Cancer Research. 2007 ; Vol. 67, No. 18. pp. 8460-8467.
@article{a6586da6953e4f9c91d49a58133d4463,
title = "Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation",
abstract = "The oncogenic function of mutant ras in mammalian cells has been extensively investigated using multiple human and animal models. These systems include overexpression of exogenous mutant ras transgenes, conditionally expressed knock-in mouse models, and somatic cell knockout of mutant and wild-type ras genes in human cancer cell lines. However, phenotypic discrepancies between knock-in mice and transgenic mutant ras overexpression prompted us to evaluate the consequences of targeted knock-in of an oncogenic K-ras mutation in the nontumorigenic human breast epithelial cell line MCF-10A and hTERT-immortalized human mammary epithelial cells. Our results show several significant differences between mutant K-ras knock-in cells versus their transgene counterparts, including limited phosphorylation of the downstream molecules extracellular signal-regulated kinase and AKT, minor proliferative capacity in the absence of an exogenous growth factor, and the inability to form colonies in semisolid medium. Analysis of 16 cancer cell lines carrying mutant K-ras genes indicated that 50{\%} of cancer cells harbor nonoverexpressed heterozygous K-ras mutations similar to the expression seen in our knock-in cell lines. Thus, this system serves as a new model for elucidating the oncogenic contribution of mutant K-ras as expressed in a large fraction of human cancer cells.",
author = "Hiroyuki Konishi and Bedri Karakas and Abukhdeir, {Abde M.} and Josh Lauring and Gustin, {John P.} and Garay, {Joseph P.} and Yuko Konishi and Eike Gallmeier and Bachman, {Kurtis E.} and Ben, {Ho Park}",
year = "2007",
month = "9",
day = "15",
doi = "10.1158/0008-5472.CAN-07-0108",
language = "English (US)",
volume = "67",
pages = "8460--8467",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation

AU - Konishi, Hiroyuki

AU - Karakas, Bedri

AU - Abukhdeir, Abde M.

AU - Lauring, Josh

AU - Gustin, John P.

AU - Garay, Joseph P.

AU - Konishi, Yuko

AU - Gallmeier, Eike

AU - Bachman, Kurtis E.

AU - Ben, Ho Park

PY - 2007/9/15

Y1 - 2007/9/15

N2 - The oncogenic function of mutant ras in mammalian cells has been extensively investigated using multiple human and animal models. These systems include overexpression of exogenous mutant ras transgenes, conditionally expressed knock-in mouse models, and somatic cell knockout of mutant and wild-type ras genes in human cancer cell lines. However, phenotypic discrepancies between knock-in mice and transgenic mutant ras overexpression prompted us to evaluate the consequences of targeted knock-in of an oncogenic K-ras mutation in the nontumorigenic human breast epithelial cell line MCF-10A and hTERT-immortalized human mammary epithelial cells. Our results show several significant differences between mutant K-ras knock-in cells versus their transgene counterparts, including limited phosphorylation of the downstream molecules extracellular signal-regulated kinase and AKT, minor proliferative capacity in the absence of an exogenous growth factor, and the inability to form colonies in semisolid medium. Analysis of 16 cancer cell lines carrying mutant K-ras genes indicated that 50% of cancer cells harbor nonoverexpressed heterozygous K-ras mutations similar to the expression seen in our knock-in cell lines. Thus, this system serves as a new model for elucidating the oncogenic contribution of mutant K-ras as expressed in a large fraction of human cancer cells.

AB - The oncogenic function of mutant ras in mammalian cells has been extensively investigated using multiple human and animal models. These systems include overexpression of exogenous mutant ras transgenes, conditionally expressed knock-in mouse models, and somatic cell knockout of mutant and wild-type ras genes in human cancer cell lines. However, phenotypic discrepancies between knock-in mice and transgenic mutant ras overexpression prompted us to evaluate the consequences of targeted knock-in of an oncogenic K-ras mutation in the nontumorigenic human breast epithelial cell line MCF-10A and hTERT-immortalized human mammary epithelial cells. Our results show several significant differences between mutant K-ras knock-in cells versus their transgene counterparts, including limited phosphorylation of the downstream molecules extracellular signal-regulated kinase and AKT, minor proliferative capacity in the absence of an exogenous growth factor, and the inability to form colonies in semisolid medium. Analysis of 16 cancer cell lines carrying mutant K-ras genes indicated that 50% of cancer cells harbor nonoverexpressed heterozygous K-ras mutations similar to the expression seen in our knock-in cell lines. Thus, this system serves as a new model for elucidating the oncogenic contribution of mutant K-ras as expressed in a large fraction of human cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=34548710863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548710863&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-0108

DO - 10.1158/0008-5472.CAN-07-0108

M3 - Article

VL - 67

SP - 8460

EP - 8467

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 18

ER -